肝细胞癌
免疫疗法
医学
癌症研究
肝移植
肝癌
脂肪肝
肝功能
肝硬化
乙型肝炎
癌症
肿瘤科
免疫学
内科学
疾病
移植
作者
Krishna Chaitanya Amajala,Indu Priya Gudivada,Rama Rao Malla
标识
DOI:10.1615/critrevoncog.2023049893
摘要
The most typical type of liver cancer or hepatocellular carcinoma (HCC) develops from hepatocyte loss. Non-alcoholic fatty liver disease (NAFLD), viral hepatitis C and cirrhosis are the leading causes of HCC. With the Hepatitis B vaccine and medicines, there are several treatments for HCC, including liver resection, ablation, transplantation, immunotherapy, gene therapy, radiation embolization, and targeted therapy. Currently, a wide range of studies are carried out on gene therapy to identify biomarkers and pathways, which help us identify the exact stage of the disorder and reduce its effects. γδT cells have recently received much interest as a potential cancer treatment method in adaptive immunotherapy. γδT cells can quickly form connections between receptor and ligand activation. They can clonally expand and are a significant source of cytokines and chemokines. The present review provides a comprehensive understanding on the function of γδT cells in immunotherapies and how they are used to treat HCC.
科研通智能强力驱动
Strongly Powered by AbleSci AI